Antibody · 대장·직결장암

85개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved85 programs
AntibodyLimited DatastaleEli LillyPhase 2

mCapOX plus Cetuximab (mCapOX plus Cetuximab)

Colo-rectal Cancer; Capecitabine · Colorectal Cancer (CRC)

#ColorectalCancerCRC#Antibody#Phase2#monoclonal-antibody#Colo-rectalCancer+2
Trials 2Status Active
AntibodyLimited DatastaleAmMax Bio, Inc.Phase 2

pembrolizumab (Keytruda, AMG820 and pembrolizumab)

Pancreatic Cancer; Colorectal Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#monoclonal-antibody#ColorectalCancer+1
Trials 1Status Active
AntibodyLimited DatastaleEli LillyPhase 2

Adebrelimab + Cetuximab+ Chemotherapy (Adebrelimab + Cetuximab+ Chemotherapy)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleShanghai Celfuture Biotech Co.,…Phase 2

Ametumumab (Ametumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Active
AntibodyLimited DatastaleBenaroya Research InstitutePhase 2

Panitumumab or Cetuximab (Anti-EGFR, Anti-EGFR (Panitumumab or Cetuximab))

Colorectal Cancer; Cholangiocarcinoma · EGFR

#EGFR#Antibody#Phase2#monoclonal-antibody#ColorectalCancer+2
Trials 1Status Active
AntibodyLimited DatastaleGustave Roussy, Cancer Campus, …Phase 2

atezolizumab (Tecentriq, Anti-PD-L1 antibody atezolizumab)

Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma ) · PD-L1

#PD-L1#Antibody#Phase2#monoclonal-antibody#PatientsWithMetastaticTumoursCol+3
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

Bevacizumab, RHUMAB VEGF (Avastin, Avastin (Bevacizumab, RHUMAB VEGF))

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 1

bevacizumab, reference product (Avastin®, Avastin® (bevacizumab, reference product))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase1#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleHighlight TherapeuticsPhase 2

pembrolizumab (Keytruda, BO-112 with pembrolizumab)

Colorectal Cancer; Gastric Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#GastricCancer+1
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 1

Brivanib + Cetuximab (Brivanib + Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleTae Won KimPhase 2

durvalumab (Imfinzi, CKD-516 plus Durvalumab)

Colorectal Cancer; Solid Tumor · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#SolidTumor+1
Trials 1Status Discontinued
AntibodyLimited DatastaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB009 (CMAB009)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#monoclonal-antibody#Taizhou
Trials 1Status Active
AntibodyLimited DatastaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#monoclonal-antibody#Caigang
Trials 1Status Recruiting
AntibodyLimited DatastaleKing Faisal Specialist Hospital…Preclinical

Capecitabine (Xelodaâ, Capecitabine, Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®))

Colon Rectal Cancer Duke Stage Stageval · Colon Rectal Cancer Duke Stage Stageval

#ColonRectalCancerDukeStageStagev#Antibody#Preclinical#monoclonal-antibody#King
Trials 1Status Active
AntibodyLimited DatastaleUniversity of Medicine and Dent…Phase 2

Capecitabine and Cetuximab (Capecitabine and Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#University
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNeovii BiotechPhase 3

Removab (Catumaxomab, Catumaxomab (Removab))

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast); Malignant Ascites · EpCam Positive Tumor (e.g.Ovarian, Gastr

#EpCamPositiveTumoregOvarianGastr#Antibody#Phase3#monoclonal-antibody#EpCamPositiveTumoregOvarian+3
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#monoclonal-antibody#ColorectalCancerMetastatic+1
Trials 1Status Recruiting
AntibodyLimited DatastaleHoffmann-La RochePhase 1

Cibisatamab (Cibisatamab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#Hoffmann-La
Trials 1Status Discontinued
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting

2 / 5 pages

← PreviousNext →